Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GSK6097608 |
Trade Name | |
Synonyms | GSK-6097608|GSK 6097608|Anti-CD96 Monoclonal Antibody GSK6097608 |
Drug Descriptions |
GSK6097608 is a monoclonal antibody targeting the tumor transmembrane protein, CD96, which may lead to inhibition of downstream signaling upon binding to CD96-expressing immune cells, thereby restoring T cell and NK cell function, and potentially resulting in an antitumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C176029 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Dostarlimab-gxly + EOS-448 + GSK6097608 | Dostarlimab-gxly EOS-448 GSK6097608 | 0 | 1 |
Dostarlimab-gxly + GSK6097608 | Dostarlimab-gxly GSK6097608 | 0 | 2 |
GSK6097608 | GSK6097608 | 0 | 1 |